Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Goodwin

Showing results (401-410 of 416) with videos related to

Pageof 42
Sort By:
Psychopharmacology Bulletin|October 1, 1980
Sleep disturbance in depression: diagnostic potential and pathophysiology [proceedings]J C Gillin, N Sitaram, W C Duncan, et al.
Journal of Affective Disorders|July 6, 2015
Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trialRif S El-Mallakh, Paul A Vöhringer, Michael M Ostacher, et al.
Journal of Affective Disorders|August 25, 2017
Corrigendum to: Antidepressants worsen rapid-cycling course in bipolar disorder: A STEP-BD randomized clinical trial. J. Affect. Disord. (Jun. 10, 2015); http://dx.doi.org/10.1016/j.jad.2015.04.054R S El-Mallakh, P A Vohringer, M M Ostacher, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and managementJoseph R Calabrese, John R Sullivan, Charles L Bowden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
ACNP Task Force report on SSRIs and suicidal behavior in youthJ John Mann, Graham Emslie, Ross J Baldessarini, et al.
The Journal of Clinical Psychiatry|April 23, 2010
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safetyS Nassir Ghaemi, Michael M Ostacher, Rif S El-Mallakh, et al.
Psychopharmacology Bulletin|October 1, 1982
Melatonin secretion as a neurobiological "marker" and effects of light in humansA J Lewy, T A Wehr, N E Rosenthal, et al.
The Journal of Clinical Psychiatry|April 7, 2012
Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatientsRobert M Post, Gabriele S Leverich, Lori L Altshuler, et al.
The American Journal of Psychiatry|February 1, 1981
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patientsD Pickar, G C Davis, S C Schulz, et al.
Journal of Clinical Psychopharmacology|August 13, 2015
Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation TrialPaul A Vöhringer, Michael J Ostacher, Rif S El-Mallakh, et al.
Pageof 42

Showing results (401-410 of 416) with videos related to

Sort By:
Pageof 42
Psychopharmacology Bulletin|October 1, 1980
Sleep disturbance in depression: diagnostic potential and pathophysiology [proceedings]J C Gillin, N Sitaram, W C Duncan, et al.
Journal of Affective Disorders|July 6, 2015
Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trialRif S El-Mallakh, Paul A Vöhringer, Michael M Ostacher, et al.
Journal of Affective Disorders|August 25, 2017
Corrigendum to: Antidepressants worsen rapid-cycling course in bipolar disorder: A STEP-BD randomized clinical trial. J. Affect. Disord. (Jun. 10, 2015); http://dx.doi.org/10.1016/j.jad.2015.04.054R S El-Mallakh, P A Vohringer, M M Ostacher, et al.
The Journal of Clinical Psychiatry|November 26, 2002
Rash in multicenter trials of lamotrigine in mood disorders: clinical relevance and managementJoseph R Calabrese, John R Sullivan, Charles L Bowden, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|December 2, 2005
ACNP Task Force report on SSRIs and suicidal behavior in youthJ John Mann, Graham Emslie, Ross J Baldessarini, et al.
The Journal of Clinical Psychiatry|April 23, 2010
Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safetyS Nassir Ghaemi, Michael M Ostacher, Rif S El-Mallakh, et al.
Psychopharmacology Bulletin|October 1, 1982
Melatonin secretion as a neurobiological "marker" and effects of light in humansA J Lewy, T A Wehr, N E Rosenthal, et al.
The Journal of Clinical Psychiatry|April 7, 2012
Relationship of prior antidepressant exposure to long-term prospective outcome in bipolar I disorder outpatientsRobert M Post, Gabriele S Leverich, Lori L Altshuler, et al.
The American Journal of Psychiatry|February 1, 1981
Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patientsD Pickar, G C Davis, S C Schulz, et al.
Journal of Clinical Psychopharmacology|August 13, 2015
Antidepressants in Type II Versus Type I Bipolar Depression: A Randomized Discontinuation TrialPaul A Vöhringer, Michael J Ostacher, Rif S El-Mallakh, et al.
Pageof 42